Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT02027701 · COMPLETED
Trial details
- NCT number
- NCT02027701
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-30
- Primary completion
- 2017-07-10
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.